Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Antihypertensive and antianginal efficacy of mibefradil confirmed in clinical trials

Nov. 6, 1997

New avenue opened for the treatment of congestive heart failure

Nov. 5, 1997

Antihypertensive effects reported for kallikrein gene therapy

Nov. 5, 1997

Zaprinast potentiates beneficial effects of inhaled NO in hypoxic pulmonary hypertension

Nov. 5, 1997

Novel antihypertensive agent developed in Taiwan

Nov. 4, 1997

Human safety, immunogenicity and pharmacokinetics reported for h5G1.1-scFV

Nov. 3, 1997

Pharmacokinetics of anti-CD11b MAb in patients undergoing aneurysm repair

Nov. 3, 1997

Clevidipine lowers MAC of anesthetic in animal study

Nov. 3, 1997

Phase II results promising for E-047/1 following CABG

Nov. 3, 1997

Merck KGaA reports two new series of ET antagonists

Nov. 3, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...